Device User Fee Reauthorization Plan Supported At Public Forum
This article was originally published in The Gray Sheet
Executive Summary
FDA's plan to reauthorize the medical device user fee program was greeted with nearly universal support at a public meeting to solicit stakeholder input April 30
You may also be interested in...
MDUFMA Renewal Plan Spreads Fee Burden More Evenly; Senate Panel OKs
Just two days after FDA released its behind-schedule proposal to reauthorize the medical device user fee program, a Senate committee approved the agency's recommendations to collect almost $300 million from manufacturers through 2012
FDA Will Drop “Cycle” Goals, Prioritize Interactive Device Reviews
FDA is proposing to eliminate premarket review interim "cycle" goals in order to prioritize more informal, interactive reviews and final approval decision times under a plan for reauthorization of the medical device user fee program released April 16
U.S. Med-Tech Field Garners $2.63 Bil. In Venture Capital In 2006, Up 20%
A record $2.63 billion in venture capital was funneled into U.S. medical device and equipment firms in 2006, a 20.3% increase from 2005, according to an Ernst & Young/Dow Jones VentureOne report released Jan. 22